Edition:
United States

People: Tabula Rasa HealthCare Inc (TRHC.OQ)

TRHC.OQ on NASDAQ Stock Exchange Global Market

66.57USD
16 Nov 2018
Change (% chg)

$-0.28 (-0.42%)
Prev Close
$66.85
Open
$66.15
Day's High
$69.68
Day's Low
$65.43
Volume
123,028
Avg. Vol
122,908
52-wk High
$91.11
52-wk Low
$27.25

Knowlton, Calvin 

Dr. Calvin H. Knowlton, Ph.D. serves as Chairman of the Board, Chief Executive Officer, Co-Founder of the Company. He has served as Chairman and Chief Executive Officer of CareKinesis since May 2009. Dr. Calvin Knowlton founded excelleRx Inc., a national hospice medication management pharmacy serving the elderly, where he acted as President and Chief Executive Officer from April 1995 through July 2007. Dr. Knowlton currently serves on the Board of The Evergreens, an Acts Community, the Board of the Cooper Medical School of Rowan University, and the Session of the First Presbyterian Church of Moorestown. Dr. Calvin Knowlton previously served on the Board of Coriell Institute for Medical Research, the Board of St. Christopher’s Hospital for Children in Philadelphia and the Board of Settlement Music School in Philadelphia. Dr. Knowlton has also served on the national Pharmacogenomics Advisory Group from 2011 to 2012, as President of the American Pharmacists Association from 1994 to 1996, and President of the American Pharmacist Association Foundation from 2008 to 2009. Dr. Knowlton received the Ernst & Young Entrepreneur of the Year technology award for the Greater Philadelphia Region in 2003 and in 2013. Dr. Knowlton was also awarded the highest national honor in pharmacy, the Remington Honor Medal, in 2015. Dr. Calvin Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary and his Ph.D. in Pharmacoeconomics from the University of Maryland. Dr. Calvin Knowlton is married to Dr. Orsula Knowlton.

Basic Compensation

Total Annual Compensation, USD 930,923
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 762,146
Fiscal Year Total, USD 1,693,070

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --